Why the study?
Does medium dose aspirin reduce graft occlusion more than low dose aspirin in patients after coronary surgery?
Population
Patients after coronary surgery
Comparison
Medium dose aspirin therapy vs Low dose aspirin therapy
Design
Meta-analysis
Follow-up
within the first year
Authors
Loading...
No significant reduction in graft occlusion with medium- versus low-dose aspirin; leaves open optimal dosing after coronary surgery.
Does medium dose aspirin reduce graft occlusion more than low dose aspirin in patients after coronary surgery?
Medium dose aspirin may be more effective than low dose aspirin in reducing graft occlusion within the first year after coronary surgery, though the difference did not reach statistical significance.
Eric Lim (2003) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: